Angiotensin-Converting Enzyme Inhibitors May Up Lung CA Risk

Share this content:
Angiotensin-Converting Enzyme Inhibitors May Up Lung CA Risk
Angiotensin-Converting Enzyme Inhibitors May Up Lung CA Risk

TUESDAY, Oct. 30, 2018 (HealthDay News) -- The use of angiotensin-converting enzyme inhibitors (ACEIs) is associated with an increased risk for lung cancer compared with angiotensin receptor blockers, according to a study published online Oct. 24 in the BMJ.

Blánaid M. Hicks, Ph.D., from Jewish General Hospital in Montreal, and colleagues conducted a population-based cohort study involving 992,061 patients newly treated with antihypertensive drugs to examine whether use of ACEIs versus angiotensin receptor blockers was correlated with the risk for lung cancer.

The researchers identified 7,952 incident lung cancer events during a mean follow-up of 6.4 years. Compared with the use of angiotensin receptor blockers, ACEI use was correlated with an increased risk for lung cancer (incidence rate, 1.6 versus 1.2 per 1,000 person-years; hazard ratio, 1.14). With longer duration of use, hazard ratios gradually increased, with an association evident after five years of use and peaking after more than 10 years (hazard ratios, 1.22 and 1.31, respectively). The findings were similar for time since initiation.

"Although the magnitudes of the observed estimates are modest, these small relative effects could translate into large absolute numbers of patients at risk for lung cancer, so these findings need to be replicated in other settings," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »